Diabetic kidney disease in Australia: Current burden and future projections

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Nephrology

• Publication date

  2014-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/nep.12281PMID 24888506
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Australia and New Zealand Dialysis and Transplant Registry

  2015cited by this paper
• Kidney disease and increased mortality risk in type 2 diabetes.

  2013cited by this paper
• The cost of diabetes in adults in Australia.

  2013influential reference
• US Renal Data System 2012 Annual Data Report.

  2013cited by this paper
• Health Care Costs in People With Diabetes and Their Association With Glycemic Control and Kidney Function

  2013cited by this paper
• Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study.

  2012influential reference
• NIH, U. . Renal Data System: Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States.

  2012cited by this paper
• Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis.

  2012cited by this paper
• Population Approaches to Improve Diet, Physical Activity, and Smoking Habits: A Scientific Statement From the American Heart Association

  2012cited by this paper
• Increases in renal replacement therapy in Australia and New Zealand: Understanding trends in diabetic nephropathy

  2012influential reference
• Temporal trends in the prevalence of diabetic kidney disease in the United States.

  2011cited by this paper
• Diabetic kidney disease with and without albuminuria

  2011cited by this paper
• Chronic kidney disease as a coronary disease equivalent--a comparison with diabetes over a decade.

  2011influential reference
• A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening.

  2010cited by this paper
• Early recognition and prevention of chronic kidney disease.

  2010cited by this paper
• Population based screening for chronic kidney disease: cost effectiveness study

  2010cited by this paper
• Projected Progression of the Prevalence of Obesity in Australia

  2010cited by this paper
• Incidence of Treatment for End-Stage Renal Disease Among Individuals With Diabetes in the U.S. Continues to Decline

  2010cited by this paper
• Projecting the burden of diabetes in Australia – what is the size of the matter?

  2009cited by this paper
• Lifetime risk and projected population prevalence of diabetes

  2008cited by this paper
• A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.

  2007cited by this paper
• Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey

  2006cited by this paper
• Divergent trends in the incidence of end‐stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998–2002

  2006cited by this paper
• Incidence of end-stage renal disease in patients with type 1 diabetes.

  2005cited by this paper
• Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes—the Linköping Diabetes Complications Study

  2004cited by this paper
• Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

  2004cited by this paper
• The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease.

  2003cited by this paper
• Screening for proteinuria in US adults: a cost-effectiveness analysis.

  2003cited by this paper
• Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

  2003cited by this paper
• The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study.

  2002cited by this paper
• The WHO Multinational Study of Vascular Disease in Diabetes.

  2001cited by this paper
• Mortality and causes of death in the WHO multinational study of vascular disease in diabetes

  2001cited by this paper
• Follow-up of the WHO multinational study of vascular disease in diabetes: general description and morbidity

  2001cited by this paper
• Risk factors for cardiovascular mortality and morbidity: The WHO multinational study of vascular disease in diabetes.

  2001influential reference
• Increased urinary albumin excretion and its associations in the WHO Multinational Study of Vascular Disease in Diabetes

  2001cited by this paper
• The WHO multinational study of vascular disease in diabetes

  2001cited by this paper
• Albuminuria and Poor Glycemic Control Predict Mortality in NIDDM

  1995influential reference
• From Australia

  1956cited by this paper

• The incidence of cardiac surgery in adults with treated kidney failure in Australia: a retrospective cohort study.

  2025cites this paper
• ABCDE to identify and prevent chronic kidney disease: a call to action

  2025cites this paper
• Analysis of correlation between dietary fiber intake and risk of diabetic kidney disease in adults with type 2 diabetes mellitus: results from the United States National Health and Nutrition Examination Surveys 2009–2018

  2025cites this paper
• Renal microcirculation and mechanisms in diabetic kidney disease

  2025cites this paper
• A review of albuminuria testing rates in people with diabetes mellitus: poor guideline adherence.

  2025cites this paper
• Effects of melatonin supplementation on oxidative stress, and inflammatory biomarkers in diabetic patients with chronic kidney disease: a double-blind, randomized controlled trial

  2025cites this paper
• Hotspots of kidney failure: Analysing Australian metropolitan dialysis demand for service planning.

  2024cites this paper
• Education programmes for people with chronic kidney disease and diabetes.

  2024cites this paper
• Relationship of the Neutrophil–Lymphocyte Ratio with All-Cause and Cardiovascular Mortality in Patients with Diabetic Kidney Disease: A Prospective Cohort Study of NHANES Study

  2024cites this paper
• Genetic Risk Scores Identify People at High Risk of Developing Diabetic Kidney Disease: A Systematic Review

  2023cites this paper
• Identifying disease progression in chronic kidney disease using proton magnetic resonance spectroscopy.

  2023cites this paper
• Mitochondrial Dysfunction in Individuals with Diabetic Kidney Disease: A Systematic Review

  2022cites this paper
• The association of attained age, age at diagnosis, and duration of type 2 diabetes with the long-term risk for major diabetes-related complications.

  2022cites this paper
• Resistant Starch as a Dietary Intervention to Limit the Progression of Diabetic Kidney Disease

  2022cites this paper
• Arterial Stiffness as a Cardiovascular Risk Factor After Successful Kidney Transplantation in Diabetic and Nondiabetic Patients.

  2022cites this paper
• Rapidly progressive crescentic diabetic nephropathy: two case reports

  2022cites this paper
• Transplant Prognosis in Kidney Transplant Recipients with Diabetes under Mycophenolic Acid-Focused Therapeutic Drug Monitoring

  2021cites this paper
• Risk Factors for Albuminuria in Normotensive Older Adults with Type 2 Diabetes Mellitus and Normal Renal Function: A Cross-Sectional Study

  2021cites this paper
• Adherence to guideline-recommended HbA1c testing frequency and better outcomes in patients with type 2 diabetes: a 5-year retrospective cohort study in Australian general practice

  2021cites this paper
• Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019

  2021cites this paper
• Young adult onset type 2 diabetes versus type 1 diabetes: Progression to and survival on renal replacement therapy.

  2021cites this paper
• AKAP1 mediates high glucose‐induced mitochondrial fission through the phosphorylation of Drp1 in podocytes

  2020cites this paper
• Low-intensity shockwave therapy in the treatment of diabetic nephropathy: a prospective Phase 1 study.

  2020cites this paper
• Oxidative Stress and Inflammation in Renal and Cardiovascular Complications of Diabetes

  2020cites this paper
• The Recipient of a Renal Transplant

  2019cites this paper
• Preventing CKD in Developed Countries

  2019cites this paper
• The Global Epidemiology of Diabetes and Kidney Disease.

  2018cites this paper
• A Review of Diabetic Kidney Disease

  2017cites this paper
• Reducing major risk factors for chronic kidney disease.

  2017cites this paper
• Epidemiological Transition of End-Stage Kidney Disease in Oman

  2016cites this paper
• 2,3,5,4'-Tetrahydroxystilbene-2-O-β-d-glucoside exerted protective effects on diabetic nephropathy in mice with hyperglycemia induced by streptozotocin.

  2016cites this paper
• Retrospective evaluation of potentially inappropriate prescribing in hospitalized patients with renal impairment

  2015cites this paper
• Quality of Life among End-stage Renal Disease Treatments and Economic Evaluation of Renal Transplantation and Hemodialysis Treatments

  2015cites this paper